NDC 51672-4046-01 - Enalapril Maleate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4046
- Requested NDC
- 51672-4046-01
- Package NDCs from labels
- 51672-4046-1, 51672-4046-3, 51672-4046-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | NuCare Pharmaceuticals,Inc. | 2021-02-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate and Hydrochlorothiazide - Rebel Distributors Corp | Rebel Distributors Corp | 2010-12-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4046-1 | Enalapril Maleate and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 51672-4046-3 | Enalapril Maleate and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4046 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4046-1 | EA - Each | 51672-4046 | 0843b439-9694-412b-a9b3-6db98999e827 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate 10 gr | SODIUM BICARBONATE | GRAXCELL PHARMACEUTICAL, LLC | 897dbb09-fb47-4e03-8cae-bf76d48a7a03 | 2025-12-25 | Warnings | 8MDF5V39QO |
| Zegerid OTC | OMEPRAZOLE, SODIUM BICARBONATE | Riley Consumer Care LLC | 1d764fc5-8eae-4fc9-a2e9-3f1954a3ac05 | 2025-12-24 | Warnings | 8MDF5V39QO |
| BABY ANTI MONKEY BUTT DIAPER RASH | ZINC OXIDE, CALAMINE | Clarion Brands, LLC | e4424d74-f89c-5943-42e8-bf3a38e68619 | 2025-12-23 | Warnings | 1K09F3G675 |
| ATACAND HCT | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | d91152c4-66ba-466f-b4f9-0da628d42b1d | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Candesartan Cilexetil and Hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | bd8d318d-167a-4b26-935d-265dde3193de | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | QPharma, Inc. | c80b2164-3795-6668-e053-2a95a90a4d45 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 466dd0d2-9815-4c3e-b66b-d0732b3ba8e9 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| SODIUM BICARBONATE | SODIUM BICARBONATE | ProPharma Distribution | 3867f743-c2cf-a646-e063-6394a90a82e1 | 2025-12-18 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| After Bite Advanced | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 223d1de8-7940-bbdc-e063-6294a90a51d8 | 2025-12-18 | Warnings | 8MDF5V39QO |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | 181324c5-256f-4570-a0bb-8bc908deb2e2 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f9faec8a-2b71-47bb-a296-48ecbce9af50 | 2025-12-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Enalapril maleate | ENALAPRIL MALEATE | Wilshire Pharmaceuticals, Inc. | c7934b45-eb6b-44c1-bd2c-ef0fa10850c1 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Epaned | ENALAPRIL MALEATE | Azurity Pharmaceuticals, Inc. | e6dbda02-779e-420c-893d-d0fea09432be | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma, Inc. | c9c44c37-bb49-4364-9293-3c8fd51b759e | 2025-12-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| INZIRQO | HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | 41aaea48-6c1b-42c8-a96f-5923d49dc934 | 2025-12-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma, Inc. | 9cd5d16e-3db7-4b25-847d-6de91543463b | 2025-12-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Exforge HCT | AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | 18d7820d-471f-4ee2-9ec6-25d8d27c77de | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| SinuCleanse | SODIUM BICARBONATE, SODIUM CHLORIDE | ASCENT CONSUMER PRODUCTS, INC. | beb842fa-2373-4f21-9631-ef20ee124584 | 2025-12-10 | Warnings | 8MDF5V39QO |
| All natural Saline Packets CareOne | SODIUM BICARBONATE, SODIUM CHLORIDE | FOODHOLD U.S.A. | e32f105d-65cd-8095-e053-2995a90a9b6b | 2025-12-10 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.